1　宋述梅 ,寿成超 .血管内皮细胞生长因子受体 (KDR)的分子克隆与原核表达 .中国生物化学与分子生物学报 (Song Shou-mei,Shou Cheng-chao.Molecular cloning and expression of vascularendothelial growth factor receptor KDR.Chin J Biochem MolBiol) ,1998,14 (1) :5 7～ 6 1 2　安平 ,董志伟 ,寿成超 .可溶性 VEGF受体 Flt-1的分子克隆及原核表达产物活性 .中国生物化学与分子生物学报 (An Ping,Dong Zhi-wei,Shou Cheng-chao.Gene cloning of soluble VEGFreceptor F lt-1and the activity of products expressed byprokaryote system.Chin J Biochem Mol Biol) ,2 0 0 0 ,16 (1) :6 2～ 6 6 3　 Tanaka K,Yamaguchi S,Sawano A,Shibuya M.Characteri-za-tion of the extracellular domain in vascular endothelial growthfactor receptor-1(Flt-1tyrosine kinase) .Jpn J Cancer Res,1997,88:86 7～ 876 4　 Glatt H J,Vu M T,Burger P C,Clintworth G K.Effect of irra-diation on vascularization of comeas grafted onto chorioallantoicmembranes.Invest Ophthalmol Vis Sci,1985 ,2 6 :15 33～ 15 42 5　 Crum R,Szabo S,F olkman J.A new class of steroids inhibitsangiogenesis in the presence of heparin or a heparin fragment.Science,1985 ,2 30 :1375～ 1378 6　 Keyt B A,Nguyen H V,Berlean L T,Duarte C M,Park J,ChenH,Ferrara N.Identification of vascular endothelial growth fac-tor determinants for binding KDR and Flt-1receptors J BiolChem,1996 ,2 71:5 6 38～ 5 6 46 7　 Davis-Smyth T,Presta L G,Ferrara N.Mapping the chargedresidues in the second imm unoglobulin-like domain of the vas-cular endothelial growth factor/placenta growth factor receptorFlt-1required for binding and structural stability.J Biol Chem,1998,2 73:32 16～ 32 2 2 8　 Fairbrother W J,Christinger h W,Cunningham B C.Novel pep-tides selected to bind vascular endothelial growth factor targetthe receptor-binding site.Biochemistry,1998,37(5 1) :1775 4～1776 4 9　 Muller Y A,L i B,Christinger H W,Wells JA,Cunningham BC,DE Vos A M.Vascular endothelial growth factor:crystalstructure and functional mapping of the kinase domain receptorbinding site.Proc N atl Acad Sci USA,1997,94:7192～ 7197